Evidence map›Paper›PMID 33893597›Full record

ArticleInternational journal of clinical pharmacy2021

Enhancing medication therapy in Parkinson's disease by establishing an interprofessional network including pharmacists.

Olaf Rose, Svenja Happe, Tessa Huchtemann, Constanze Mönig, Michael Ohms, Oliver Schwalbe, Tobias Warnecke, Susanne Erzkamp

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Editorial.International journal of clinical pharmacy · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Olaf RoseImpac2t Research, Maximilianstr. 31-33, Münster, Germany. rose@elefantenapo.de.ORCID http://orcid.org/0000-0003-1681-4909
Svenja HappeKlinik Maria Frieden Telgte, Telgte, Germany.
Tessa HuchtemannDepartment of Neurology, University of Münster, Münster, Germany.
Constanze MönigDepartment of Neurology, University of Münster, Münster, Germany.
Michael OhmsKlinik für Neurologie mit Klinischer Neurophysiologie, Herz-Jesu-Krankenhaus Hiltrup, Westfalenstr. 109, Münster, Germany.
Oliver SchwalbeApothekerkammer Westfalen-Lippe, Münster, Germany.
Tobias WarneckeDepartment of Neurology, University of Münster, Münster, Germany.
Susanne ErzkampImpac2t Research, Maximilianstr. 31-33, Münster, Germany.
University of Münster · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Optimizing therapy regimens through collaboration and combination of available resources is a promising approach to improve quality of life for patients with Parkinson's disease (PD). Aim The aim of this project was to enhance patient-oriented therapy and interprofessional collaboration by establishing a regional PD network. Setting The network is located in a rural area in Germany. It covers primary, secondary and tertiary care facilities across professional boundaries. Development Recruitment of PD specialists and patient support groups was done by the local newspaper to spread the word. The network was initially open to all healthcare professionals, who stated a focus or special interest in PD. A working group for medication was founded within the network by asking for interested participants. Problems in the medication process were discussed within the group. As a consequence, therapy recommendations (quickcards) and a specific medication plan were developed and a certified education curriculum for pharmacists was developed. Implementation The network grew to > 150 participants across all disciplines and sectors. Quickcards were adjusted, approved and implemented by the network during interquartile meetings. Certified education was implemented and became a requirement for participating pharmacists. Evaluation The quickcards on medication plan and drug-drug-interactions were approved to be useful and feasible by the network by unanimous assent. Overall satisfaction with certified education was high (mean of 1.4 on a scale between 1 = high and 6 = low). Conclusion A regional interprofessional PD network with pharmacists was established and new standards were established. Future research needs to measure the effects on patient outcomes.

Indexed as

Parkinson DiseasePharmacistsHealth PersonnelHumansInterprofessional RelationsQuality of LifeClinical pharmacyIntegrated careInterprofessionalNetworkNeurologyParkinson's diseasePharmacist

Identifiers

PMID33893597
OpenAlexW3154878744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.